Clinical Trial Search

Primary: Percentatge of Doravirine Dialysis Extraction Ratio (ER) — 34.3 percentage of doravirine dialysis ER

Primary: Number of Participants Who Did HIV Testing — 36; 9 Participants

Primary: The Prevalence of Neurocognitive Deficits Among HIV-positive Patients as Defined by the Global Deficit Score Based on the Neuropsychological Testing Battery and to…

Primary: Hemoglobin A1c Levels — 7.1; 7.1 percent — p=0.67

Primary: Death — 0 Participants

Primary: Number of Participants ≥90% Adherent to Antiretroviral Medication Based on MEMS Cap Openings — 9; 5 Participants — p=0.32

Primary: Visits With PrEP Dispensation to Female Study Participants Reporting Sexual Behaviors or STI Symptoms — 211 Visits

Primary: Intervention Feasibility- Number of Participants Enrolled in Each Arm — 5; 43; 44 Participants

Primary: Mean Systolic Blood Pressure Over the Third Month of Each Treatment Arm — 139; 142 mm Hg

Primary: Number of Particpatns Who Considered the Intervention Feasible and Acceptable — 20 participants

Primary: Mean Absolute Relative Difference Between CGM Value and Capillary Blood Glucose (Self-monitoring Blood Glucose [SMBG]) — 13.8 percent difference

Primary: Change in the Concentration of High Sensitivity C-Reactive Protein (hsCRP) From Baseline to 12 Weeks — -2.6; 0.8 mg/dl — p=0.03

Primary: Number of TH Clients Who Received HIV Testing — 57; 250 Participants — p=<0.001

Primary: Number of Participants With Sustained Virological Response 6 Months After Treatment Discontinuation — 10 Participants

Primary: Proportion Adherent to ARV and Psychotropic Medication by Electronic Monitoring System (MEMS) — 90.3; 90.0; 83.9; 90.0 percentage of taken doses — p=0.95